| 1 |
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
John Dormandy et al. · The Lancet
Open access |
Oct 2005 |
4,157 |
| 2 |
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Eric Van Cutsem et al. · Annals of Oncology
Open access |
5 Jul 2016 |
3,512 |
| 3 |
EAU Guidelines on Interventional Treatment for Urolithiasis
Christian Türk, Aleš Petřík, Kemal Sarıca et al. · European Urology
|
4 Sep 2015 |
1,843 |
| 4 |
EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis
Christian Türk, Aleš Petřík, Kemal Sarıca et al. · European Urology
|
29 Aug 2015 |
969 |
| 5 |
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Juan W. Valle, Ivan Borbath, Shahid Ahmed Khan et al. · Annals of Oncology
Open access |
Sep 2016 |
694 |
| 6 |
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients
Johannes Sch�ller, Jim Cassidy, Etienne F. Dumont et al. · Cancer Chemotherapy and Pharmacology
|
6 Mar 2000 |
669 |
| 7 |
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
Sonja Kleffel et al. · Cell
Open access |
Sep 2015 |
657 |
| 8 |
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
S. Krege et al. · European Urology
|
14 Jan 2008 |
618 |
| 9 |
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
John B. Buse, Michael Albrecht Nauck, Thomas M. Forst et al. · The Lancet
|
6 Nov 2012 |
567 |
| 10 |
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?
Wolfgang Pf Miehsler, W Reinisch, E Valic et al. · Gut
Open access |
11 Mar 2004 |
482 |
| 11 |
Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea
Guntram Schernthaner, Jorge Luiz Gross, Julio Rosenstock et al. · Diabetes Care
Open access |
6 Apr 2013 |
482 |
| 12 |
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
Juergen Floege, Jae Bum Kim, Elizabeth Ireland et al. · Nephrology Dialysis Transplantation
Open access |
25 Apr 2010 |
479 |
| 13 |
Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke
Robert Wilcox, Marie‐Germaine Bousser, D. J. Betteridge et al. · Stroke
|
9 Feb 2007 |
476 |
| 14 |
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Martina Sanlorenzo, Igor Vujic, ADIL I. DAUD et al. · JAMA Dermatology
Open access |
29 Jul 2015 |
456 |
| 15 |
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
Julio Rosenstock, Melanie J. Davies, Philip Home et al. · Diabetologia
Open access |
15 Jan 2008 |
448 |
| 16 |
Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients
H-G. Kopp, Christoph W. Kopp, Andreas Festa et al. · Arteriosclerosis Thrombosis and Vascular Biology
Open access |
29 Apr 2003 |
429 |
| 17 |
Diabetes Mellitus in Older People: Position Statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes
Alan J. Sinclair, John Edward Morley, Leocadio Rodríguez‐Mañas et al. · Journal of the American Medical Directors Association
Open access |
28 Jun 2012 |
426 |
| 18 |
Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: EAU Guidelines
Andreas A. Skolarikos, Michael Straub, Thomas Martin Knoll et al. · European Urology
|
20 Nov 2014 |
422 |
| 19 |
EAU Guidelines on Testicular Cancer: 2011 Update
Peter Albers, Walter Albrecht, Ferrán Algaba et al. · European Urology
|
27 May 2011 |
410 |
| 20 |
Hypoglycemia and Cardiovascular Risks
Brian M. Frier, Guntram Schernthaner, Simon R. Heller · Diabetes Care
Open access |
22 Apr 2011 |
377 |
| 21 |
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non‐diabetic controls
Christian A. Bannister, Sarah E. Holden, Sara Jenkins‐Jones et al. · Diabetes Obesity and Metabolism
|
7 Jul 2014 |
362 |
| 22 |
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial
Thomas Gruenberger, John A. Bridgewater, Ian Chau et al. · Annals of Oncology
Open access |
23 Dec 2014 |
361 |
| 23 |
The Immunology of Fibrosis
Georg Wick, Cecilia Grundtman, Christina Mayerl et al. · Annual Review of Immunology
ReviewOpen access |
21 Mar 2013 |
335 |
| 24 |
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype
Mohammed Iqbal Hawa et al. · Diabetes Care
Open access |
18 Dec 2012 |
334 |
| 25 |
Recommendations on basic requirements for intensive care units: structural and organizational aspects
Andreas Valentin, Patrick Ferdinande, ESICM Working Group on Quality Improvement · Intensive Care Medicine
Open access |
14 Sep 2011 |
333 |
| 26 |
Guidelines on Testicular Cancer
Peter Albers, Walter Albrecht, Ferrán Algaba et al. · European Urology
|
19 Jul 2005 |
316 |
| 27 |
Reflux, Sleeve Dilation, and Barrett’s Esophagus after Laparoscopic Sleeve Gastrectomy: Long-Term Follow-Up
Daniel Moritz Felsenreich, Ronald Kefurt, Martin Schermann et al. · Obesity Surgery
|
7 Jun 2017 |
303 |
| 28 |
Transplantation of the RPE in AMD
Susanne Binder, Boris V. Stanzel, Ilse Krebs et al. · Progress in Retinal and Eye Research
|
8 Mar 2007 |
294 |
| 29 |
Paediatric Gastrointestinal Endoscopy
Mike A. Thomson et al. · Journal of Pediatric Gastroenterology and Nutrition
Open access |
13 Sep 2016 |
286 |
| 30 |
Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study
Kamlesh K. Khunti, Saud N. Alsifri, Ronnie Aronson et al. · Diabetes Obesity and Metabolism
Open access |
10 May 2016 |
280 |
| 31 |
Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM)
Andrew Rhodes, Rui Paulo Moreno, Élie Azoulay et al. · Intensive Care Medicine
Open access |
26 Jan 2012 |
280 |
| 32 |
GUIDE study: double‐blind comparison of once‐daily gliclazide MR and glimepiride in type 2 diabetic patients
Gerit-Holger Schernthaner, André Grimaldi, Umberto Di Mario et al. · European Journal of Clinical Investigation
Open access |
Aug 2004 |
271 |
| 33 |
Efficacy and Safety of Pioglitazone Versus Metformin in Patients with Type 2 Diabetes Mellitus: A Double-Blind, Randomized Trial
Guntram Schernthaner, David Richard Matthews, Bernard H. Charbonnel et al. · The Journal of Clinical Endocrinology & Metabolism
|
Dec 2004 |
269 |
| 34 |
Inflammatory Bowel Disease Is a Risk Factor for Recurrent Venous Thromboembolism
Gottfried Novacek et al. · Gastroenterology
|
14 Jun 2010 |
265 |
| 35 |
Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response
Péter Ferenci, Hermann Laferl, Thomas–Matthias Scherzer et al. · Gastroenterology
|
18 Apr 2008 |
253 |
| 36 |
Immunogenicity and Allergenic Potential of Animal and Human Insulins
Guntram Schernthaner · Diabetes Care
|
Dec 1993 |
251 |
| 37 |
Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study
Birgit Gruenberger, Johannes Schueller, Ute Heubrandtner et al. · The Lancet Oncology
|
10 Nov 2010 |
245 |
| 38 |
Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo
Christian Posch, Homayoun Moslehi, Luzviminda Feeney et al. · Proceedings of the National Academy of Sciences
Open access |
19 Feb 2013 |
238 |
| 39 |
Langerhans cell histiocytosis in children
Jolie Krooks, Milen Minkov, Angela G. Weatherall · Journal of the American Academy of Dermatology
|
10 May 2018 |
236 |
| 40 |
Outcome of Transplantation of Autologous Retinal Pigment Epithelium in Age-Related Macular Degeneration: A Prospective Trial
Susanne Binder, Ilse Krebs, R.-D Hilgers et al. · Investigative Ophthalmology & Visual Science
|
25 Oct 2004 |
234 |
| 41 |
One-Year Glycemic Control With a Sulfonylurea Plus Pioglitazone Versus a Sulfonylurea Plus Metformin in Patients With Type 2 Diabetes
M Hanefeld, Paolo Brunetti, Guntram Schernthaner et al. · Diabetes Care
|
2004 |
231 |
| 42 |
Small-bowel neoplasms in patients undergoing video capsule endoscopy: a multicenter European study
Emanuele Rondonotti, Marco Pennazio, Ervin Tóth et al. · Endoscopy
Open access |
8 May 2008 |
228 |
| 43 |
Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study
Susanne Binder, ULRIKE STOLBA, Ilse Krebs et al. · American Journal of Ophthalmology
|
Feb 2002 |
225 |
| 44 |
Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass: 10-year results of laparoscopic sleeve gastrectomy
Daniel Moritz Felsenreich, Felix Benedikt Langer, Ronald Kefurt et al. · Surgery for Obesity and Related Diseases
|
27 Feb 2016 |
221 |
| 45 |
Three-dimensional optical coherence tomography at 1050 nm versus 800 nm in retinal pathologies: enhanced performance and choroidal penetration in cataract patients
Boris Považay, Boris Hermann, Angelika Unterhuber et al. · Journal of Biomedical Optics
Open access |
2007 |
211 |
| 46 |
Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women
H Kopp, Katarzyna Krzyżanowska, Matthias Möhlig et al. · International Journal of Obesity
|
3 May 2005 |
191 |
| 47 |
Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?
Philip Home, Matthew C. Riddle, William T. Cefalu et al. · Diabetes Care
Open access |
10 May 2014 |
177 |
| 48 |
Intracavernous Injection of Prostaglandin E1 in Impotent Men
Walter Stackl, Rudolf Hasun, Michael Marberger · The Journal of Urology
|
Jul 1988 |
175 |
| 49 |
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study
David Richard Matthews, Bernard H. Charbonnel, M Hanefeld et al. · Diabetes/Metabolism Research and Reviews
|
15 Jun 2004 |
175 |
| 50 |
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes
Bernard H. Charbonnel, Guntram Schernthaner, Philip Brunetti et al. · Diabetologia
Open access |
12 May 2005 |
170 |